Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8021 | 1226 | 50.5 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1072 | 9457 | ELECTRIC FISH//ELECTRIC ORGAN DISCHARGE//LATERAL LINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ZEBRAFISH | Journal | 10 | 16% | 5% | 61 |
2 | UNITE MACROPHAGES DEV IMMUNITE | Address | 8 | 62% | 1% | 8 |
3 | MOL CELLULAR PHARMACOL PHARMACOGEN PHARM | Address | 5 | 50% | 1% | 7 |
4 | STEM CELL PROGRAMHEMATOL ONCOL PROGRAM | Address | 4 | 75% | 0% | 3 |
5 | STEM CELL PROGRAM HEMATOL ONCOL | Address | 3 | 57% | 0% | 4 |
6 | TRANSFARLAND | Address | 3 | 57% | 0% | 4 |
7 | UNITE MACROPHAGES DEV IMMUN | Address | 3 | 45% | 0% | 5 |
8 | ZEBRAFISH MODELING DRUG SCREENING HUMAN | Address | 3 | 50% | 0% | 4 |
9 | MRC DEV BIOMED GENET | Address | 3 | 16% | 1% | 16 |
10 | CARLOTA SALDANHA | Address | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BILIARY DEVELOPMENT | 2 | 67% | 0% | 2 | Search BILIARY+DEVELOPMENT | Search BILIARY+DEVELOPMENT |
2 | MPX | 2 | 67% | 0% | 2 | Search MPX | Search MPX |
3 | CHEMICAL SCREEN | 2 | 26% | 0% | 5 | Search CHEMICAL+SCREEN | Search CHEMICAL+SCREEN |
4 | PRIMITIVE HEMATOPOIESIS | 1 | 31% | 0% | 4 | Search PRIMITIVE+HEMATOPOIESIS | Search PRIMITIVE+HEMATOPOIESIS |
5 | DEYOLKING | 1 | 100% | 0% | 2 | Search DEYOLKING | Search DEYOLKING |
6 | ENDODERM FORMATION | 1 | 50% | 0% | 2 | Search ENDODERM+FORMATION | Search ENDODERM+FORMATION |
7 | IN VIVO DRUG DISCOVERY | 1 | 100% | 0% | 2 | Search IN+VIVO+DRUG+DISCOVERY | Search IN+VIVO+DRUG+DISCOVERY |
8 | LEUKOCYTE BIOLOGY | 1 | 100% | 0% | 2 | Search LEUKOCYTE+BIOLOGY | Search LEUKOCYTE+BIOLOGY |
9 | NETWORK PATHWAY | 1 | 50% | 0% | 2 | Search NETWORK+PATHWAY | Search NETWORK+PATHWAY |
10 | PRIMITIVE AND DEFINITIVE HEMATOPOIESIS | 1 | 100% | 0% | 2 | Search PRIMITIVE+AND+DEFINITIVE+HEMATOPOIESIS | Search PRIMITIVE+AND+DEFINITIVE+HEMATOPOIESIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSGENIC ZEBRAFISH | 94 | 32% | 20% | 247 |
2 | REGULATED TRANSGENIC ZEBRAFISH | 32 | 80% | 2% | 20 |
3 | EXPOSURE ROUTES | 27 | 70% | 2% | 23 |
4 | EARLY MACROPHAGES | 24 | 60% | 2% | 26 |
5 | MYELOID SPECIFIC EXPRESSION | 23 | 79% | 1% | 15 |
6 | CAUSES GENOME INSTABILITY | 19 | 71% | 1% | 15 |
7 | CLOCHE | 16 | 51% | 2% | 23 |
8 | CLONAL ZEBRAFISH | 14 | 100% | 1% | 7 |
9 | ANTIANGIOGENIC COMPOUNDS | 11 | 78% | 1% | 7 |
10 | DIFFERENT DEVELOPMENTAL STAGES | 10 | 28% | 2% | 30 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ZEBRAFISH | 10 | 16% | 5% | 61 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
15 years of zebrafish chemical screening | 2015 | 2 | 68 | 40% |
Macrophage-pathogen interactions in infectious diseases: new therapeutic insights from the zebrafish host model | 2014 | 12 | 116 | 41% |
Animal models of human disease: zebrafish swim into view | 2007 | 577 | 110 | 38% |
Zebrafish cancer: the state of the art and the path forward | 2013 | 33 | 109 | 55% |
Zebrafish: A New Companion for Translational Research in Oncology | 2015 | 1 | 51 | 53% |
Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era | 2014 | 5 | 90 | 64% |
Real-time imaging and genetic dissection of host-microbe interactions in zebrafish | 2014 | 4 | 83 | 63% |
Host-microbe interactions in the developing zebrafish | 2010 | 74 | 99 | 45% |
Host-Pathogen Interactions Made Transparent with the Zebrafish Model | 2011 | 61 | 190 | 39% |
Zebrafish and Streptococcal Infections | 2015 | 1 | 69 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNITE MACROPHAGES DEV IMMUNITE | 8 | 62% | 0.7% | 8 |
2 | MOL CELLULAR PHARMACOL PHARMACOGEN PHARM | 5 | 50% | 0.6% | 7 |
3 | STEM CELL PROGRAMHEMATOL ONCOL PROGRAM | 4 | 75% | 0.2% | 3 |
4 | STEM CELL PROGRAM HEMATOL ONCOL | 3 | 57% | 0.3% | 4 |
5 | TRANSFARLAND | 3 | 57% | 0.3% | 4 |
6 | UNITE MACROPHAGES DEV IMMUN | 3 | 45% | 0.4% | 5 |
7 | ZEBRAFISH MODELING DRUG SCREENING HUMAN | 3 | 50% | 0.3% | 4 |
8 | MRC DEV BIOMED GENET | 3 | 16% | 1.3% | 16 |
9 | CARLOTA SALDANHA | 3 | 60% | 0.2% | 3 |
10 | ENDOTHELIAL MOL BIOL | 3 | 60% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208218 | BOZOZOK//EPIBOLY//NO TAIL |
2 | 0.0000168548 | ZEBRAFISH NEUROSCI CONSORTIUM//MORFOL CIENCIAS FISIOL//ZNRC |
3 | 0.0000108151 | FUNDULUS HETEROCLITUS//BLUE SAC DISEASE//ELIZABETH RIVER |
4 | 0.0000096174 | HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//AORTA GONAD MESONEPHROS |
5 | 0.0000090619 | DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION |
6 | 0.0000079505 | CARDIAC LOOPING//LEFT ATRIAL LIGATION//EMBRYONIC CIRCULATION |
7 | 0.0000074191 | MAUTHNER CELL//MAUTHNER//MAUTHNER NEURON |
8 | 0.0000059040 | COMFREY//SYMPHYTUM HERB EXTRACT//BORC IBST |
9 | 0.0000058470 | SCOTTISH FISH IMMUNOL//LIPOPOLYSACCHARIDE INDUCED TNF ALPHA FACTOR//LITAF |
10 | 0.0000051478 | INTEGRATED BIOSCI 102//WORLDS MEDAKA AQUARIUM//NOMORHAMPHUS |